NCT03868098View on ClinicalTrials.gov

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

November 25, 2020

Study Completion Date

November 25, 2020

Conditions
Dermatitis, Atopic
Interventions
DRUG

Crisaborole 2%

Crisaborole ointment 2% (application rate A, B, C) for 15 days (double blind)

DRUG

Placebo ointment

Placebo ointment (vehicle)

Trial Locations (1)

H2X 2V1

Innovaderm Research Inc., Montreal

Sponsors
All Listed Sponsors
lead

Innovaderm Research Inc.

OTHER

NCT03868098 - Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter